Published Date: 28-Feb-2022
Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support
According to a new report Global Aptamers Market, published by KBV research, The Global Aptamers Market size is expected to reach $392.7 million by 2027, rising at a market growth of 17.6% CAGR during the forecast period.
RNA Aptamers segment has high growth rate of 19.9% during (2021 - 2027). The growth of this segment is due to its high therapeutic as well as diagnostic value. With the recent FDA approval of the first aptamer medication and more in the trial pipelines, RNA aptamers have proven to be of considerable therapeutic and diagnostic significance.
Therapeutics Development is leading the segment in the Global Aptamers Market by Application 2020, thereby, achieving a market value of $180.5 million by 2027, growing at a CAGR of 16.5 % during the forecast period. The growth of the segment is a result of a rise in clinical studies testing aptamers for new medicines and cooperation between aptamer companies and important pharmaceutical and biotechnology corporations.
SELEX acquired maximum revenue share in the Global Aptamers Market by Technology 2020, and would continue to be a dominant market till 2027; thereby, achieving a market value of $313.7 million by 2027, growing at a CAGR of 16.9 % during the forecast period. The Others market is expected to witness highest CAGR of 20.7% during (2021 - 2027).
The Academic & Government Research Institutes shows highest growth rate of 18.4% during (2021 - 2027). The increased growth of this segment of the aptamers market can be attributed to the constantly and rapidly increasing number of funding and investments on the researches intending to discover solutions for the treatment of various chronic diseases and disorders including a variety of cancers as well as cardiovascular disorders.
The North America market is the fastest growing region in the Global Aptamers Market by Region 2020, and would continue to be a dominant market till 2027; thereby, achieving a market value of $171.3 million by 2027. The Europe market is expected to witness a CAGR of 17.1% during (2021 - 2027). Additionally, The Asia Pacific market is expected to witness a CAGR of 17.7% during (2021 - 2027).
Full Report: https://www.kbvresearch.com/aptamers-market/
The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Kaneka Corporation, Aptamer Group PLC, SomaLogic, Inc., RayBiotech Life, Inc., Neoventures Biotechnology, Inc., Maravai Lifesciences Holdings, Inc., Aptus Biotech, Base Pair Biotechnologies, Inc., Alpha Diagnostic International, Inc., and Vivonics, Inc.
By End User
Unique Offerings from KBV Research